IgG response to SARS-CoV-2 and seasonal coronaviruses contributes to complement overactivation in severe COVID-19 patients

Excessive complement activation has been implicated in the pathogenesis of COVID-19, but the mechanisms leading to this response remain unclear. We measured plasma levels of key complement markers, SARS-CoV-2 RNA and antibodies against SARS-CoV-2 and common cold coronaviruses (CCC) in hospitalized p...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases 2022-03
Main Authors: Castanha, Priscila M S, Tuttle, Dylan J, Kitsios, Georgios D, Jacobs, Jana L, Braga-Neto, Ulisses, Duespohl, Matthew, Rathod, Sanjay, Marti, Michelle M, Wheeler, Sarah, Naqvi, Asma, Staines, Brittany, Mellors, John, Morris, Alison, McVerry, Bryan J, Shah, Faraaz, Schaefer, Caitlin, Macatangay, Bernard J C, Methe, Barbara, Fernandez, Christian A, Barratt-Boyes, Simon M, Burke, Donald, Marques, Ernesto T A
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Excessive complement activation has been implicated in the pathogenesis of COVID-19, but the mechanisms leading to this response remain unclear. We measured plasma levels of key complement markers, SARS-CoV-2 RNA and antibodies against SARS-CoV-2 and common cold coronaviruses (CCC) in hospitalized patients with COVID-19 of moderate (n=18) and critical severity (n=37), and healthy control subjects (n=10). We confirmed that complement activation is systemically increased in COVID-19 patients and is associated with a worse disease outcome. We showed that plasma levels of C1q and circulating immune complexes (CIC) were markedly increased in severe COVID-19 patients and correlated with higher IgG titers, greater complement activation and higher disease severity score. Additional analyses showed that the classical pathway was the main arm responsible for augmented complement activation in severe patients. In addition, we demonstrated that a rapid IgG response to SARS-CoV-2 and an anamnestic IgG response to the nucleoprotein of the CCC were strongly correlated with CIC levels, complement activation, and disease severity. These findings indicate that early, non-neutralizing IgG responses may play a key role in complement overactivation in severe COVID-19. Our work underscores the urgent need to develop therapeutic strategies to modify complement overactivation in COVID-19 patients.
ISSN:1537-6613
DOI:10.1093/infdis/jiac091